missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ralimetinib dimesylate, MedChemExpress
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
Description
Ralimetinib dimesylate (LY2228820 dimesylate) is a selective, ATP-competitive inhibitor of p38 MAPK α/β with IC50s of 5.3 and 3.2 nM, respectively. Ralimetinib (LY2228820) selectively inhibits phosphorylation of MK2 (Thr334), with no effect on phosphorylation of p38a MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc.
Specifications
Specifications
| Chemical Name or Material | Ralimetinib dimesylate |
| CAS | 862507-23-1 |
| Color | Yellow |
| Purity Grade Notes | Research |
| Molecular Formula | C26H37FN6O6S2 |
| Quantity | 10 mg |
| Synonym | LY2228820 dimesylate |
| Solubility Information | DMSO : 61 mg/mL (99.55 mM; Need ultrasonic and warming) |
| SMILES | FC1=CC=C(C=C1)C2=C(NC(C(C)(C)C)=N2)C3=NC4=C(C=C3)N=C(N)N4CC(C)(C)C.OS(C)(=O)=O.OS(C)(=O)=O |
| Molecular Weight (g/mol) | 612.74 |
| Show More |
Research purposes only
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction